FREE SHIPPING ON ORDERS OVER $150

ascendis pharma glp-1 receptor agonist weight management diabetes treatments medications GLP-1 receptor agonists in the treatment of type 2 – state-of-the-art Endocrinology Newsmakers: Drugmakers work on

$28.12

Quantity
- +
Description

& Baldeweg, S

ascendis pharma glp-1 receptor agonist weight management diabetes treatments medications GLP-1 receptor agonists in the treatment of type 2 state-of-the-art Endocrinology Newsmakers: Drugmakers work on

Common Side Effects Both medications cause primarily gastrointestinal effects: Saxenda common side effects: Nausea (39%) Diarrhea (21%) Constipation (19%) Vomiting (16%) Injection site reactions (14%) Headache (14%) Dyspepsia (10%) Semaglutide common side effects: Nausea (44%) Diarrhea (30%) Vomiting (24%) Constipation (24%) Abdominal pain (20%) Headache (14%) Fatigue (11%) Side Effect Comparison Table Interpreting the Numbers Semaglutide appears to have higher rates of GI side effects in clinical trials

ascendis pharma glp-1 receptor agonist weight management diabetes treatments medications GLP-1 receptor agonists in the treatment of type 2 state-of-the-art Endocrinology Newsmakers: Drugmakers work on

Secondary analyses were performed to assess complication rates as a combined odds ratio (OR) compared to the placebo group in the meta-analyses

ascendis pharma glp-1 receptor agonist weight management diabetes treatments medications GLP-1 receptor agonists in the treatment of type 2 state-of-the-art Endocrinology Newsmakers: Drugmakers work on

10.1124/pr.55.1.6

ascendis pharma glp-1 receptor agonist weight management diabetes treatments medications GLP-1 receptor agonists in the treatment of type 2 state-of-the-art Endocrinology Newsmakers: Drugmakers work on

You may also like

recommand products